Deficiency of NOX1/Nicotinamide Adenine Dinucleotide Phosphate, Reduced Form Oxidase Leads to Pulmonary Vascular Remodeling
Author(s) -
K Iwata,
Kanako Ikami,
Kuniharu Matsuno,
Toshiharu Yamashita,
Dai Shiba,
Masakazu Ibi,
Misaki Matsumoto,
Masato Katsuyama,
Wenhao Cui,
Jia Zhang,
Kai Zhu,
Norio Takei,
Yasuo Kokai,
Osamu Ohneda,
Takahiko Yokoyama,
Chihiro YabeNishimura
Publication year - 2013
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.113.302107
Subject(s) - nox1 , nicotinamide adenine dinucleotide phosphate , nadph oxidase , biology , microbiology and biotechnology , endocrinology , medicine , chemistry , oxidase test , oxidative stress , biochemistry , enzyme
Involvement of reactive oxygen species derived from nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase has been documented in the development of hypoxia-induced model of pulmonary arterial hypertension (PAH). Because the PAH-like phenotype was demonstrated in mice deficient in Nox1 gene (Nox1(-/Y)) raised under normoxia, the aim of this study was to clarify how the lack of NOX1/NADPH oxidase could lead to pulmonary pathology.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom